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Abstract
Background: Adult skeletal muscles are composed of slow and fast myofiber subtypes which each express
selective genes required for their specific contractile and metabolic activity. Six homeoproteins are transcription
factors regulating muscle cell fate through activation of myogenic regulatory factors and driving fast-type gene
expression during embryogenesis.
Results: We show here that Six1 protein accumulates more robustly in the nuclei of adult fast-type muscles than in
adult slow-type muscles, this specific enrichment takes place during perinatal growth. Deletion of Six1 in soleus
impaired fast-type myofiber specialization during perinatal development, resulting in a slow phenotype and a
complete lack of Myosin heavy chain 2A (MyHCIIA) expression. Global transcriptomic analysis of wild-type and Six1
mutant myofibers identified the gene networks controlled by Six1 in adult soleus muscle. This analysis showed that
Six1 is required for the expression of numerous genes encoding fast-type sarcomeric proteins, glycolytic enzymes
and controlling intracellular calcium homeostasis. Parvalbumin, a key player of calcium buffering, in particular, is a
direct target of Six1 in the adult myofiber.
Conclusions: This analysis revealed that Six1 controls distinct aspects of adult muscle physiology in vivo, and acts
as a main determinant of fast-fiber type acquisition and maintenance.
Keywords: Six1, Myosin heavy chain, Skeletal muscle, Slow and fast myofibers, Soleus, Pvalb
Abbreviations: Aldh1a1, Aldehyde dehydrogenase family 1, subfamily A1; Aldoa, Aldolase A, fructose-bisphosphate;
ANOVA, Analysis of variance; Atp2a1, ATPase, Ca++ transporting, cardiac muscle, fast twitch 1; Atp2a2, ATPase, Ca++
transporting, cardiac muscle, slow twitch 2; Baf60c, Brahma-associated factor 60c; Chnrg, Cholinergic receptor,
nicotinic, gamma polypeptide; Cidea, Cell death-inducing DNA fragmentation factor, alpha subunit-like effector A;
ciSix1, Six1flox/flox; HSA-Cre-ERT2, Conditional inducible knockout mice; CRE, Cre recombinase; cSix1, Six1flox/flox; HSA-
Cre, Human skeletal actin–CRE conditional knockout mice; Ctrl, Control mice; Ddit4l, DNA-damage-inducible
transcript 4-like; EDL, Extensor digitorum longus muscle; EMSA, Electrophoretic mobility shift assay; Eno3, Enolase 3,
beta muscle; Esr1, Estrogen receptor 1 (alpha); Eya1, EYA transcriptional coactivator and phosphatase 1;
Gck, Glucokinase; GP, Gastrocnemius plantaris muscle; GPDH, Glycerophosphate dehydrogenase; Hdac, Histone
deacetylase; HSA, Human skeletal actin promoter; Ldha, Lactate dehydrogenase A; MCIP1, Myocyte-enriched
calcineurin-interacting protein-1; MEF2, Myocyte enhancer factor 2; MEF3, Myocyte enhancer factor 3;
MRFs, Myogenic regulatory factors; Mybpc2, Myosin binding protein C, fast-type; Myh, Myosin heavy chain;
MyHC, Myosin heavy chain; Mylpf, Myosin light chain, phosphorylatable, fast skeletal muscle; Myoz1, Myozenin 1;
NFAT, Nuclear factor of activated T cells; Nuak1, NUAK family, SNF1-like kinase, 1; PBS, Phosphate buffered saline;
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Pdk3, Pyruvate dehydrogenase kinase, isoenzyme 3; PFA, Paraformaldehyde; Pfkfb1, 6-phosphofructo-2-kinase/
fructose-2,6-biphosphatase 1; Pfkm, phosphofructokinase, muscle; Pgc1α, Peroxisome proliferative activated
receptor, gamma, coactivator 1 alpha; PPARβ/δ, Peroxisome proliferator activator receptor delta; Prox1, Prospero
homeobox 1; Ptgr1, Prostaglandin reductase 1; Pvalb, Parvalbumin; Rspo3, R-spondin 3; Ryr3, Ryanodine receptor 3;
SDH, Succinate dehydrogenase; SEM, Standard error of the mean; SERCA, Sarcoendoplasmic reticulum calcium
transport ATPase; Six1, Sine oculis-related homeobox 1; SOL, Soleus muscle; Sox6, SRY (sex determining region Y)-
box 6; TA, Tibialis anterior; TFAM, Transcription factor A, mitochondrial; TK, Thymidine kinase; Tnnc, Troponin C;
Tnnt, Troponin T
Background
Adult skeletal muscles are composed of slow and fast
myofiber types, and each skeletal muscle is composed of
a stereotyped percentage of myofibers of different sub-
types. Myofiber types are characterized by the expression
of slow- or fast-type sarcomeric proteins and specific
Ca2+-handling proteins that modulate its intracellular
concentration during the excitation/contraction/relax-
ation cycle, by their glycolytic and mitochondrial oxida-
tive metabolic properties as well as by their myoglobin
content [1–4]. More specifically, the formation of slow
or fast sarcomeric units is achieved by the expression of
fiber-type specific isoforms of sarcomeric genes such as
myosin heavy chain (MyHCI, MyHCIIA, MyHCIIX,
MyHCIIB), troponin C (Tnnc1, Tnnc2), troponin I
(Tnni1, Tnni2), and troponin T (Tnnt1, Tnnt3). Their
metabolic properties are determined by glycolytic en-
zymes (Gck, Aldoa, Pfkm, Pfkfb1, Eno3) and by mito-
chondrial oxidative enzymes [5]. Upon motoneuron
firing, stimulation intramyofibrillar Ca2+ is released from
the sarcoplasmic reticulum to trigger muscle contraction
through its binding to troponin C, and further activation
of myosin heavy chain ATPase. The cytosolic Ca2+ re-
uptake is carried out by the sarcoplasmic reticulum
SERCA proteins encoded by slow-type Atp2a2 and fast-
type Atp2a1 [1–4]. SERCA activity is regulated by
sarcolipin (Sln), expressed in slow and fast oxidative fi-
bers, by phospholamban (Pln) and by myoregulin (Mln)
expressed in fast fibers, known repressors of SERCA
activity [6, 7] through binding to SERCA proteins [8–10].
In fast-type fibers, parvalbumin (Pvalb), a Ca2+ buffering
protein, removes Ca2+ efficiently from the cytosol to pro-
mote relaxation of the myofiber [11].
In adult skeletal muscle, the expression of fiber type-
specific genes is coordinated by transcription factors
whose activity is modulated by cascades of signaling
pathways connected with the environment; mainly by
Ca2+ flux induced by motoneuron stimulation, O2, hor-
mones and nutrients availability. Slow motoneuron firing
leads to sustained low amplitude elevation in intramyofi-
brillar calcium concentrations able to activate calcineurin,
and CamK while fast motoneuron firing leads to brief
intramyofibrillar calcium transients of high amplitude that
do not activate calcineurin [12, 13]. Activated calcineurin
and CaMK increase the activity of NFAT and MEF2 tran-
scription factors leading to slow sarcomeric gene expres-
sion [14, 15]. Muscle mitochondrial oxidation activity
which is increased during exercise is under the control of
PPARβ/δ and PGC1α and PGC1β, two transcriptional
coactivators of PPARβ/δ and activators of oxidative me-
tabolism [16–18]. Whereas muscle specific deletion of
both PGC1α and PGC1β does not change muscle fiber
type [19], muscle-specific deletion of PPARβ/δ leads to an
increased number of fast fibers with reduced oxidative
capacity [20], while PPARβ/δ ectopic expression in adult
myofibers can change both myosin heavy chain content
and oxidative metabolism [21]. Upstream regulators
controlling fast myofiber phenotypes are HDACs, Sox6
and Linc-Myh known to suppress slow-type gene expres-
sion in fast myofibers [15, 22–25], MyoD [26] and Six1
[25, 27]. Hif1α regulates the expression of genes coding
for enzymes of the glycolysis pathway, but its deletion
does not lead to major modification of the expression of
fiber-type specific sarcomeric proteins while it impairs
metabolic adaptation upon exercise [28]. Little is known
however concerning the importance of these fiber-type
regulators in the coordinated expression of slow or fast
genes during perinatal development, the period when
muscle fiber specialization takes place [1, 2]. In particular,
the mechanisms presiding at the expression of a single fast
Myh gene in hundreds nuclei of a myofiber have not yet
been elucidated [25, 29, 30].
Six homeoproteins are major myogenic transcription
factors that directly bind to DNA sequences called
MEF3s to control embryonic myogenesis [31–34] and
genesis of fast-type myofibers [29, 35]. Forced expression
of Six1 and its Eya1 cofactor in adult slow myofibers can
reprogram adult slow-twitch oxidative fibers toward a
fast-twitch glycolytic phenotype [31]. In adult fast-type
skeletal muscles, Six1 directly regulates the expression of
numerous fast-type muscle genes [25]. Furthermore,
Six1 interacts with the central enhancer of the Myh fast
genes locus, and controls the expression of the fast-type
Myh genes (MyHCIIA, MyHCIIX, MyHCIIB) [25].
While Six1 has been detected in soleus (SOL) muscle
at the mRNA and protein levels, its physiological role in
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slow-type muscles has not been explored [25]. Mouse
C57bl6N SOL is classified as a slow-type skeletal muscle,
composed of approximately 60 % of slow-type/oxydative
myofibers and 40 % of fast-type/oxydative myofibers. In
this study, we analyzed the phenotypic consequences of
Six1 loss in SOL myofibers during mouse perinatal de-
velopment and in adult. We show that Six1 governs the
specification of fast MyHCIIA myofibers and is required
for the maintenance of MyHCIIA expression.
Methods
Animals and ethics statement
Animal experimentation was carried out in strict accord-
ance with the European convention STE 123 and the
French national charter on the Ethics of Animal Experi-
mentation. Protocols were approved by the Ethical Com-
mittee of Animal Experiments of the Institut Cochin,
CNRS UMR 8104, INSERM U1016. Surgery was per-
formed under ketamine/xylazine anesthesia, and all
efforts were made to minimize suffering. Six1flox/flox;
HSA-Cre conditional knockout mice (cSix1KO) were ob-
tained by breeding the Six1-LoxP mice and transgenic
mice expressing a CRE recombinase under the control
of the human skeletal actin promoter (HSA) [20]. Six1-
flox/flox; HSA-Cre-ERT2 conditional inducible knockout
mice (ciSix1 KO) were obtained by breeding the Six1-
LoxP mice and HSA-CRE-ERT2 mice [36]. two-month-
old ciSix1 KO males were given intraperitoneal injection
of tamoxifen (1 mg per mouse per day; Sigma) for five
consecutive days.
Immunohistochemistry
For Six1 immunostaining, SOL and gastrocnemius plan-
taris (GP) muscles were embedded in cryomatrix and
quickly frozen in isopentane cooled with liquid nitrogen.
Cryostat sections (10 μm) were fixed in 4 % PFA and
washed in 1× PBS. The sections were treated with Anti-
gen Unmasking Solution (H-3300, Vector Laboratories)
at 95 °C for 10 min and washed in 1× PBS for three
times. Sections were treated with 1 % H2O2 solution for
20 min. After three washes in 1× PBS, they were perme-
abilized with 0.1 % Triton X-100 for 20 min and left for
1 h in blocking solution (1× PBS, 1.5 % goat serum,
0.1 % Triton X-100). Rabbit polyclonal antibodies
directed against Six1 (HPA001893, Sigma) (1/100
dilution), and dystrophin (NCL-DYS2, Leica Biosystems)
(1/50 dilution) were applied overnight at 4 °C to the
treated sections. The next day, after three washes with
1× PBS containing 0.05 % Tween-20, sections were incu-
bated for 1 h with appropriate fluorescent secondary
antibodies (Alexa Fluor 594 goat anti-mouse IgG 1/1000
dilution, Invitrogen) and biotynilated secondary anti-
bodies (anti-rabbit IgG 1/200, Vector Laboratories).
After three washes with 1× PBS containing 0.05 %
Tween-20, samples were incubated in VECTASTAIN
Elite ABC Reagent (Vector Laboratories) for 30 min.
After three washes with 1× PBS containing 0.05 %
Tween-20, samples were incubated with a tyramide solu-
tion labeled by Alexa Fluor 488 (Tyramide Signal Ampli-
fication kit, invitrogen). After three washes with 1× PBS
containing 0.05 % Tween-20, samples were mounted in
Vectashield mounting medium.
For determination of Myh isoform expression, SOL
and GP muscles were embedded in cryomatrix and
quickly frozen in isopentane cooled with liquid nitrogen.
Cryostat sections (10 μm) were washed in PBS, perme-
abilized with 0.1 % Triton X-100 for 20 min and left for
1 h in blocking solution (1× PBS, 1.5 % goat serum,
0.1 % Triton X-100). Rabbit poly-clonal antibodies
directed against Laminin (Z0097, Dako) (1/100 dilution),
and mouse monoclonal antibodies against MyHCI
(NOQ7.5.4D, Sigma) (1/1000 dilution), MyHCIIA
(SC-71, Developmental Studies Hybridoma Bank) (1/
20 dilution), fast MyHCs (My-32, Sigma) (1/50 dilu-
tion) and MyHCemb (F1.652, sc-53091 Santa Cruz
Biotechnology, Inc.) (1/20 dilution) were applied
overnight at 4 °C to the treated sections. The next
day, after three washes with 1× PBS containing 0.05 %
Tween-20, sections were incubated for 1 h with appropri-
ate fluorescent secondary antibodies (Alexa Fluor 488 goat
anti-rabbit IgG 1/1000 dilution, Alexa Fluor 594 goat anti-
mouse IgG 1/1000 dilution, Invitrogen). After three
washes with 1× PBS containing 0.05 % Tween-20, samples
were mounted in Vectashield mounting medium. For fiber
type counting, each MyHC positive fiber was counted in
the entire SOL muscle sections, and the number of posi-
tive fibers was divided by the total SOL number of fibers.
SDH/GPDH staining
Fresh-frozen sections were incubated in 0.2 M phos-
phate buffer (pH 7.6) containing sodium succinate and
nitroblue tetrazolium, NBT (N6876, Sigma Aldrich) for
30 min at 37 °C. Sections were then washed with water
and mounted in glycerine gelatin medium. GPDH stain-
ing was performed by incubation of unfrozen muscle
sections with α-glycerol phosphate as described [37]. For
quantification of SDH and GPDH staining, the color
images were converted to thresholded images at hue
(121-208) and brightness (0-140) by a threshold tool of
ImageJ software. The area of thresholded images was
measured by ImageJ and normalized by the whole soleus
muscle area.
RNA preparation
Soleus muscles were collected from cSix1 KO and control
mice. Total RNAs were extracted using Trizol Reagent
(Invitrogen) according to manufacturer’s instruction.
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cDNA synthesis and qPCR
RNAs were treated with DNase I (Turbo DNA-free, Invi-
trogen) and were reverse-transcribed with Superscript III
kit (Invitrogen) according to manufacturer’s instruction.
Reverse transcription was performed with 1 μg of total
RNA. Quantitative real time PCR (Light Cycler 480,
Roche) was performed using Light Cycler 480 SYBR
Green I Master Kit (Roche) according to the manufac-
turer’s protocols. PCR was performed for 40 cycles of 95 °
C for 15 s, 60 °C for 15 s, and 72 °C for 15 s. Gene expres-
sion levels were normalized by the expression level of the
housekeeping gene Actb. The sequences of the oligonucle-
otides used in this study are given in Additional file 1:
Table S1.
ChIP experiments
GP and tibialis anterior (TA) muscles of 2 months old
female mice were minced with scissors immediately after
harvesting and fixed in 1 % formaldehyde for 10 min.
Formaldehyde was quenched by addition of 0.125 M gly-
cine, and muscles were washed twice in PBS. Muscles
were then incubated on ice in lysis buffer (10 mM Tris-
HCl pH 7.9, 85 mM KCl, 0.5 % NP40, protease inhibi-
tors (Complete, Roche)) for 10 min and homogenized
with a mortar and subsequently with a dounce
homogenizer. Nuclei were obtained by centrifugation,
incubated in SDS lysis buffer (50 mM Tris-HCl pH 8,
10 mM EDTA, 1 % SDS, protease inhibitors) for 10 min,
and sonicated in a bioruptor apparatus (Diagenode). The
debris was removed by centrifugation. Sonicated DNA
was incubated with 1 μg of Six1 antibodies (HPA001893,
Sigma) under rotation at 4 °C overnight. 20 μl of dyna-
beads protein G (Invitrogen) were added to the lysates
and incubated under rotation at 4 °C for 1 h. The beads
were washed with low-salt buffer (2 mM EDTA, 20 mM
Tris-HCl pH 8, 150 mM NaCl, 1 % TritonX-100, 0.1 %
SDS), high-salt buffer (2 mM EDTA, 20 mM Tris-HCl
pH 8, 0.5 M NaCl, 1 % TritonX-100, 0.1 % SDS), LiCl
buffer (1 mM EDTA, 10 mM Tris-HCl pH 8, 0.25 M
LiCl, 1 % NP40, 1 % deoxycholate), and TE buffer
(1 mM EDTA, 10 mM Tris-HCl pH 8). DNA was eluted
with elution buffer (1 % SDS, 0.1 M NaHCO3) contain-
ing 0.1 mg/ml proteinase K (Invitrogen) at 62 °C for 2 h,
and proteinase K was inactivated by incubation at 95 °C
for 10 min. DNA was finally purified with MinElute PCR
purification kit (Qiagen). The amount of specific ampli-
fied DNA is normalized by input amplification. The
sequences of the oligonucleotides used in this study are
as follows. Actb, 5′-TGTTACCAACTGGGACGACA-3′
and 5′-ACCTGGGTCATCTTTTCACG-3′; PvalbMEF
3_1, 5′-GGAGCCTTTCATGGTGTGAT-3′ and 5′-GG
CGTGTGAATCACTTTCCT-3′; PvalbMEF3_2, 5′- GG
ATGGGGGTGAATGTGATA-3′ and 5′- CTTCCGGTG
TCAGGTACTCC-3′.
EMSA
EMSA was carried out with Six1 and Six4 full-length
mouse cDNA cloned into the pCR3 vector (Clontech) as
previously described [38]. Recombinant mouse Six1 and
Six4 proteins were obtained separately with a T7 tran-
scription/translation kit (Promega) and mixed before
contact with the DNA. Myogenin MEF3 DNA was incu-
bated with recombinant proteins. Competition experi-
ments were performed in the presence of a tenfold and
hundredfold molar excess of unlabeled identified Pvalb
MEF3_1, Pvalb MEF3_2, Myogenin MEF3, Myod1DRR
MEF3, or Myogenin NFI sites. The sequences of the
oligonucleotides used are as follows, the MEF3 consen-
sus sequence is in italic; MyogF 5′-TGG GGG GGC
TCA GGT TTC TGT GGC GT-3′. MyogR 5′-ACG
CCA CAG AAA CCT GAG CCC CCC CA-3′. NF1F 5′-
TAT CTC TGG GTT CAT GCC AGC AGG G-3′.
NF1R 5′-CCC TGC TGG CAT GAA CCC AGA GAT
A-3′. PvalbMEF3_1F, 5′- TGA GCA TCT GTA ACC
TGA CCC TTG G -3′. PvalbMEF3_1R, 5′- CCA AGG
GTC AGG TTA CAG ATG CT-3′. PvalbMEF3_2F, 5′-
TGA GTA CCT GAC ACC GGA AGG GGA G-3′.
PvalbMEF3_2R, 5′- CTC CCC TTC CGG TGT CAG
GTA CT-3′. MyodDRRF, 5′- AGT TGG ATC CGG
TTT CCA GAG GC -3′. MyodDRRR, 5′- TGA GAC
AGT AAT TTT ATC CTG CT -3′.
Plasmids construction
For the construction of the pGL3-Pvalb, C57bl6N mouse
DNA was first used as a template to clone the 700 bp pro-
moter of Pvalb with forward MluI, 5′- GTAACCT-
GACCCTTGGAAACCAG -3′ and reverse BglII, 5′-
CTTGGATGAGCAGAGGCCGGA-3′ primers. This Pvalb
promoter fragment was subsequently inserted into an
MluI-BglII digested pGL3 basic plasmid. For the construc-
tion of the pGL3-PvalbmutMEF3-1, PvalbmutMEF3-2 and
PvalbdoublemutMEF3, the two MEF3 sites of the promoter
were mutated as follows; Pvalb MEF3-1: 5′GTAACCTGA
to 5′CGCGTCTGA; Pvalb MEF3-2: 5′GACACCGGA to
5′CTCGAGGGA. All plasmids sequences were confirmed
by sequencing.
Electroporation
In vivo transfections were also carried out on ten-week
old C57Bl6N mice. For each experimental conditions
three to five TA muscles belonging to different mice
were used. Under isoflurane anesthesia, legs were shaved
and muscles were pre-treated by injection of a sterile
0.9 % NaCl solution containing 0.4 U of bovine hyal-
uronidase/μl 2 h before plasmid injection. Two micro-
grams of Luciferase-expressing vector and one hundred ng
of pRL-TK vector (Promega) were introduced into TA
muscles of ten-week-old mice by electroporation as previ-
ously described [27]. Two weeks following electroporation,
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electroporated muscles were frozen in liquid nitrogen be-
fore processing for Luciferase assays.
Luciferase assays
Two weeks after electroporation, TA were dissected and
frozen in liquid nitrogen before processing. TA were
homogenized in Passive Lysis Buffer (Dual-Luciferase
Reporter Assay System, Promega) and rotated for
15 min. The homogenate was centrifuged to remove
debris, and the supernatant was used for Luciferase ac-
tivity measurement according to manufacturer’s instruc-
tion (Dual-Luciferase Reporter Assay System, Promega).
Microarrays
After validation of RNA quality with the Bioanalyzer
2100 (using Agilent RNA6000 nano chip kit), 50 ng of
total RNA were reverse-transcribed following the Ova-
tion PicoSL WTA System (Nugen). Briefly, the resulting
double-strand cDNA was used for amplification based
on SPIA technology. After purification according to
Nugen protocol, 5 μg of single strand DNA was used for
generation of Sens Target DNA using Ovation Exon
Module kit (Nugen). 2.5 μg of Sens Target DNA were
fragmented and labelled with biotin using Encore Biotin
Module kit (Nugen). After control of fragmentation
using Bioanalyzer 2100, the cDNA was then hybridized
to GeneChip® Mouse Gene 1.0 ST (Affymetrix) at 45 °C
for 17 h. After overnight hybridization, the ChIPs were
washed using the fluidic station FS450 following specific
protocols (Affymetrix) and scanned using the GCS3000
7G. The scanned images were then analyzed with Ex-
pression Console software (Affymetrix) to obtain raw
data (cel files) and metrics for quality controls. The ana-
lysis of some of these metrics and the study of the distri-
bution of raw data show no outlier experiment. RMA
normalization was performed using R and normalized
data was subjected to statistical tests.
Preparation of nuclear and cytosolic proteins
SOL and GP muscles of 2, 3, and 12 weeks old mice
were frozen with liquid nitrogen and were homogenized
with a mortar. Homogenates were fractionated by NE-
PER kit (78833, Thermo Scientific) according to manu-
facturer’s instruction.
Western blot
Cell or tissue lysates of GP and SOL from cSix1KO and con-
trol mice (20–40 μg) were denatured in Laemmli buffer, sep-
arated by SDS-polyacrylamide gel electrophoresis and
transferred to nitrocellulose membrane. Membranes were
blocked in 50 mM Tris-HCl pH 7.6, 137 mM NaCl and
0.1 % (v/v) Tween-20 containing 10 % (w/v) skimmed milk
or 5 % (w/v) BSA for 1 h at room temperature and incubated
overnight at 4 °C with the indicated primary antibodies
(Complex I, NADH dehydrogenase, ab14713, Abcam
(Cambridge, UK); Complex II, succinate dehydrogenase,
ab109865, Abcam (Cambridge, UK); cytochrome bc1
complex, ab110252, Abcam (Cambridge, UK); Complex
IV, cytochrome C oxidase, ab14744, Abcam (Cambridge,
UK); Complex V, ATP synthase, ab14748, Abcam (Cam-
bridge, UK); hexokinase II, Sc-6521 (Santa Cruz Biotech-
nology); glycogen synthase 1, CST #3893, Cell Signaling
Technology; AS160, 07-741, Millipore; GLUT4, kind do-
nation from Geoffrey Holman, University of Bath); lamin
B, sc-6216 (Santa Cruz Biotechnology); β-tubulin, 05-661
(Millipore); Six1, HPA001893 (Sigma). Detection was per-
formed using horseradish peroxidase conjugated second-
ary antibodies and enhanced chemiluminescence reagent.
Statistical analysis
All graphs represent mean values ± SEM. Significant dif-
ferences between mean values were evaluated using two-
tailed, unpaired Student’s t test (when two groups were
analyzed) or one-way ANOVA followed by Student
Newman-Keuls test (for three or more groups).
Microarray data accession number
Microarray data have been deposited in the Gene
Expression Omnibus as accession no. GSE50023.
Results
Six1 protein subcellular localization in adult myofibers
To analyze the properties of Six1 homeoprotein in adult
SOL muscles, we first determined its expression pattern.
We showed previously that Six1 mRNA accumulates in
both fast and slow muscles and that Six1 protein is
produced in both type of muscles but accumulates more
robustly in the nuclei of fast myofibers as evaluated by
immunohistochemistry [25, 27]. We here show that Six1
protein is produced in the GP (fast gastrocnemius and
plantaris muscles) and in the SOL of 2 weeks, 3 weeks
and adult mice (Fig. 1a), but that the nuclear accumula-
tion of Six1 is drastically reduced between 3 weeks and
the adult stage in the SOL (Fig. 1b), although no obvious
cytoplasmic Six1 accumulation is observed in the SOL
as estimated by Western blot experiments. Six1 protein
was further detected in the fast GP and the slow SOL
muscles by immunofluorescence using antibodies
directed against Six1 at several developmental stages. At
embryonic day E18.5, we observed that Six1 is present in
the nuclei of myofibers of the GP and SOL expressing at
that stage both MyHCI (slow/β) and fast MyHC
(detected by My32 antibodies that recognize MyH-
Cemb, MyHCneo and adult fast MyHC) (Fig. 1c). On
adult sections, Six1 protein accumulation was de-
tected preferentially in the nuclei of GP as compared
with SOL nuclei (Fig. 1d), in agreement with previous
results [27]. While GP muscles are mainly composed
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of myofibers expressing MyHCIIB or MyHCIIX, SOL
muscles are composed mainly by myofibers express-
ing MyHCI (slow/β), MyHCIIA and by few myofibers
expressing MyHCIIX. Nuclear Six1 is nevertheless
detected in the SOL in the fast MyHCIIA, and in
some MyHCI fibers (Fig. 1c). These results showed
that in adult hindlimb muscles, Six1 proteins
accumulate preferentially in the nuclei of GP fast
myofibers than in the nuclei of SOL myofibers
(Fig. 1c), in accordance with the low amount of Six1
proteins detected in myonuclei of SOL by Western
blot analysis (Fig. 1a), and that this preferential
nuclear Six1 accumulation takes place during the
perinatal period.
Fig. 1 Six1 proteins are predominantly localized in nuclei of fast type skeletal muscles. a, bWestern blot analysis of Six1 proteins in total lysates (a) and in
nuclear fractions (b) of GP and SOL muscles of 2-week, 3-week, and 12-week-old animals. Quantification of nuclear Six1 proteins at these developmental stages
is presented. Lamin B is used as a nuclear control protein, and α-tubulin as a cytoplasmic control protein. c Immunostaining of Six1 (green), Dystrophin (red),
MyHCI (red) Laminin (green) and MY32 (red) in soleus and gastrocnemius (GP) muscles of embryonic E18.5 mouse fetuses. The second image is an enlargement
of the yellow square drawn on the first image. White arrows indicate Six1 nuclear staining. d. Immunostaining of Six1 (green), Dystrophin (red), MyCHI (red), MyH-
CIIA (red) and Laminin (green) in SOL and GP of 20-week-old mice. The lower panels are enlargment of the yellow squares drawn on the top image.White arrows in-
dicate nuclear Six1 detection. Some MyHCI and MyHCIIA positive fibers are indicated as I or IIA, respectively. SOL soleus muscle, GP gastrocnemius plantaris muscle
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Six1 deficiency impairs adult muscle fast type phenotype
acquisition in SOL
To characterize the role of Six1 in adult SOL, we ana-
lyzed myofiber-specific Six1 knockout (cSix1 KO) mice
[25]. cSix1 KO mice were viable, and Six1 mRNA and
protein were not detectable in adult GP or SOL muscles
[25]. As fiber type specialization that leads to the expres-
sion of a single Myh gene in all the myonuclei of a given
myofiber proceeds during the neonatal stage, we next
performed immunohistochemistry to analyze the content
of MyHCI, MyHCIIA, and MyHCemb of SOL in 3-
week-old cSix1 mutant myofibers. In control (Ctrl) mice,
10 % of myofibers expressed MyHCemb, 50 % expressed
MyHCI, and 60 % expressed MyHCIIA (Fig. 2a, b). In
cSix1 KO mice, 40 % of myofibers still expressed MyH-
Cemb, 96 % of myofibers expressed MyHCI, and 33 % of
myofibers expressed MyHCIIA. This result suggested
that sustained expression of Six1 in the perinatal period
is important for embryonic to adult fast myofiber transi-
tion in SOL and that the decrease of nuclear Six1 accu-
mulation may be important to allow MyHCI exclusive
expression in slow-type SOL myofibers. It is known that
perinatal muscle growth in mice takes place by accretion
of new satellite cells (SC) [39]. As Six1 is expressed in
SC [40–42], it is possible that Six1 may be transiently
expressed by new accreted myonuclei until P21 [39], be-
fore its efficient deletion by the HSA-CRE recombinase
only active in post mitotic myofibers. To test this hy-
pothesis, we measured Six1 protein accumulation in the
nuclei of SOL at 3 weeks of development and detected
Six1 positive myonuclei in cSix1 SOL at this develop-
ment stage (Fig. 2e). This showed that HSA-CRE recom-
binase had not yet recombined the Six1 flox allele in all
P21 myonuclei, allowing Six1 to be detected in some nu-
clei of perinatal myofibers of mutant animals.
In 12-week-old adult animals, at a stage when Six1 is
no longer detected in adult cSix1 myonuclei [25], 100 %
of SOL myofibers in mutant mice expressed MyHCI
while MyHCIIA was not detectable (Fig. 2c, d), contrary
to Ctrl SOL where 45 % of myofibers expressed MyH-
CIIA and 55 % expressed MyHCI (Fig. 2c, d). In adult
cSix1 mutant SOL, MyHCIIX and MyHCIIA mRNA
became undetectable (Fig. 4b), while the amount of
MyHCI mRNA increased twice (Fig. 4b).
The number of SOL myofibers present in Ctrl and
cSix1 KO was comparable, excluding that absence of
MyHCIIA myofibers in adult mutant animals is the
consequence of their death (Additional file 2: Figure S1).
We observed no significant modification of the CSA
between wt and cSix1 KO adult myofibers, excluding
that Six1 is a main regulator of MyHCIIA myofibers
growth in SOL (Additional file 2: Figure S1).
To analyze the oxidative/glycolytic metabolism of mutant
SOL muscles, SDH, and GPDH staining were performed
on 12-week-old soleus muscle sections (Fig. 3a, b). A two-
to threefold decrease of SDH activity was observed in cSix1
SOL as compared with that of control (Fig. 3a). Neverthe-
less, no significant difference of mitochondrial protein con-
tents was observed in cSix1 SOL extracts as determined by
Western blots (Fig. 3c). We also observed a robust decrease
in GPDH activity in cSix1 SOL as compared with that of
control, suggesting that absence of Six1 decreases glycolytic
flux in adult SOL myofibers (Fig. 3b).
Networks of genes under the control of Six1 in adult SOL
To explore the networks of genes under the control of
Six1 in adult SOL, we performed Affymetrix microarray
analyses using RNA from adult Ctrl and cSix1 KO mice.
Genes whose expression is the most up- or down-
regulated (Additional file 3: Table S2) are shown as a
heat map and as a bar graph (Fig. 4a and Additional file
4: Figure S2). The expression of several fast-type genes is
down-regulated in cSix1 KO including Pvalb, Mybpc2,
MyHCIIA, Myl1, Myoz1, and Mylpf (Fig. 4a). We vali-
dated the expression of those fiber type-specific genes by
qPCR. Consistent with immunohistochemistry data,
MyHCIIA mRNA was no longer detectable in SOL of
12-week-old cSix1 KO mice, and MyHCI mRNA level
was increased by twofold as compared with control
(Fig. 4b). The expression levels of slow-type genes
(Tnnt1, Tnni1, Tnnc1) were also increased by twofold in
cSix1 KO soleus muscles while the expression of fast-
type genes Tnnt3 and Tnni2 was not detected and ex-
pression of Tnnc2 was markedly decreased (Fig. 4b).
These data show that nuclear accumulation of Six1
observed in SOL MyHCIIA-myofibers is necessary to
activate the expression of MyHCIIA and of other fast-
type sarcomeric genes and to suppress the expression of
MyHCI and other slow-type muscle genes.
The second most down-regulated gene in cSix1 SOL is
Pvalb (Fig. 4a), which is a calcium buffering protein allow-
ing muscle relaxation in fast-type muscles [11, 43–45].
Furthermore, other genes related with calcium regulation
were also modified in cSix1 KO mice (Additional file 4:
Figure S2). We validated the down-regulation of Pvalb
mRNA level in cSix1 SOL by qPCR experiments (Fig. 4c).
The expression level of Sln, Atp2a2, and Ryr3 was in-
creased in cSix1 SOL muscles while the expression of fast-
type genes Myoz1 and Atp2a1 was strongly decreased
(Fig. 4d). These data suggest that Six1 regulates intramyo-
cellular calcium transients through the control of the ex-
pression of several fiber type-specific calcium-binding
proteins, and suggest a feedback loop between Six1 nu-
clear accumulation and resting intracellular calcium
concentration.
Concerning Affymetrix results, the expression of several
genes encoding glycolytic enzymes (Aldoa, Ldha, Pfkfb1,
PFKm, and Eno3) was also down-regulated (Fig. 4a and
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Fig. 2 Six1 deficiency induced a lack of MyHCIIA fibers in soleus. a Immunostaining of MyHCI (red), MyHCIIA (red), MyHCemb (red), and laminine
(green) in soleus muscles of 3-week-old control and cSix1 KO mice. SOL soleus, GP gastrocnemius plantaris, F fibula. b Percentage of myofibers
expressing MyHCI, MyHCIIA and MyHCemb in soleus of 3-week-old control and cSix1 KO mice, Ctrl (n = 3), cSix1 (n = 3). c Immunostaining of
MyHCI (red), MyHCIIA (red), and laminine (green) in soleus of 12-week-old control and cSix1 KO mice. d Percentage of myofibers expressing MyHCI,
MyHCIIA in soleus of 12-week-old control and cSix1 KO mice, Ctrl (n = 3), cSix1 (n = 3). e Immunostaining of Six1 (green) and Dystrophin (red) in
soleus of 3 weeks old cSix1 KO mice and Ctrl mice. White arrows indicate nuclear Six1 staining. Nuclei are stained with Dapi (blue). *P < 0.05,
**P < 0.01, ***P < 0.001
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Fig. 3 Metabolic properties of cSix1 KO muscles. a SDH staining of soleus of 12-week-old cSix1 KO and wt mice, and percentage of the area of positive
fibers. b GPDH staining of soleus of 12-week-old cSix1 KO and wt mice, and percentage of the area of positive fibers. c Western blot analysis
of mitochondrial proteins and glucose metabolism proteins in SOL and GP of Ctrl and cSix1 KO mice. C2C12, mitochondrial fraction of C2C12
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Fig. 4 (See legend on next page.)
Sakakibara et al. Skeletal Muscle  (2016) 6:30 Page 10 of 20
Additional file 4: Figure S2 and Additional file 5: Figure S3).
Aldoa possesses several promoters, and its fast-type one is
a known direct target of Six proteins [25, 27]. Muscle-
specific Aldoa mRNA expression was strongly down-
regulated in SOL of cSix1 KO mice (Fig. 4c). We also ob-
served the down-regulation of Slc2a4 (Glut4) and
Tbc1d1—involved in Glut4 vesicular traffic [46]—of glyco-
lytic genes (Eno3, Pfkfb1), of muscle Creatine Kinase, of
Ldha, and Ldhd of the NAD+-dependent isocitrate de-
hydrogenase Idh3a, of Idh1, the down-regulation of Pdp1,
an activator of and the up-regulation of Pdk3 an inhibitor
of pyruvate dehydrogenase activity, and validated by qPCR
experiments of their expression (Fig. 4d). No major up- or
down-regulation of genes related with oxidative metabolism
was detected (Additional file 4: Figure S2), which is consist-
ent with the results of the Western blot analysis showing
no major modification of the quantity of the electron trans-
port chain proteins (Fig. 3c).
To investigate potential interaction between Six1 and
known fiber-type regulators that may participate down-
stream of Six1 to the observed phenotype, we analyzed
their expression levels by Affymetrix and qPCR (Fig. 4e
and Additional file 4: Figure S2). Sox6 gene, a known re-
pressor of slow sarcomeric genes [22, 24], showed a two-
fold expression decrease in SOL of cSix1 KO mice
(Fig. 4e). This down-regulation may be involved in the
up-regulation of the expression of its known slow-type
gene targets MyHCI, Tnnt1, Tnnt2, Tnni1, and Tnnc1
[22–24, 47] observed in cSix1 mutant myofibers. Expres-
sion of Esr1 gene (estrogen receptor 1), an activator of
the slow/oxidative phenotype in females [48] was de-
creased in cSix1 KO mice. We tested the expression of
Ppargc1a and Nfatc1 known transcriptional activators of
slow-oxidative genes [1, 2], but found no significant
modifications of their expression levels in SOL of cSix1
mice (Fig. 4e). We were also unable to detect modifica-
tions of the expression of mRNA encoding TFAM,
PPARβ, Rev-erb-α, or Mef2C, known transcription fac-
tors controlling the slow/oxidative phenotype of adult
myofibers (data not shown). Altogether our results
indicate that in SOL of adult mice, Six1 controls the
expression of genes coding for fast-type sarcomeric and
calcium handling proteins, for glycolytic proteins, and
for Sox6 a known repressor of slow type sarcomeric
genes; absence of Six1 leading to a myofiber switch to-
ward a slower phenotype. Interestingly, in SOL of cSix1
KO, we also observed the up-regulation of Prox1 (Fig. 4f ),
a known repressor of the fast genes Tnnt3, Tnni2,
MyHCIIA, and Myl1, and which may also account for
their down-regulation [49].
Among the genes showing the most up- or down-
regulation in mutant SOL, Affymetrix analysis also re-
vealed a strong reduction of the expression levels of
Ddit4l (Redd2) an inhibitor of the mTOR pathway [50],
Rspo3 (R-Spondin3) and Aldh1a1 and the increase of the
expression level of Nuak1 (NUAK family, SNF1-like kin-
ase, 1), Ptgr1 (Prostaglandin reductase1), Chnrγ and
Chnrα1 (Acetylcholin receptor gamma and alpha1), and
Cidea (cell death-inducing DNA fragmentation factor,
alpha subunit-like effector A), an inhibitor of AMPK
[51] (Fig. 4a). We also validated the expression of those
genes by qPCR (Fig. 4f ).
These results indicate that Six1 has a role to enhance
the glycolytic pathway in myofibers of adult SOL
through the transcription of genes coding for glycolytic
proteins, and may modulate more generally glucose
utilization in adult myofibers by modulating the expres-
sion of key modulators of glucose flux among which
Krebs cycle genes (Additional file 5: Figure S3).
Skeletal muscle-specific Tamoxifen-inducible Six1 knock-
out mice also showed fast-to-slow fiber type transition
To examine the role of Six1 in the maintenance of myo-
fibers phenotype in the adult SOL, we bred Six1flox/flox
mice with transgenic mice expressing Cre-ERT2 recom-
binase under the control of the HSA promoter [36] to
obtain Six1flox/flox; HSA-Cre-ERT2 conditional inducible
knockout mice (hereafter named ciSix1 KO), to induce
Six1 deletion after Tamoxifen injection. Eight-week-old
ciSix1 KO mice and their littermate Ctrl were injected
with Tamoxifen. One month after Tamoxifen injection,
Six1 mRNA level in ciSix1 KO was reduced by ~90 %
compared with that in Ctrl mice (Fig. 5a). We further
analyzed SOL fiber-type composition by immuno-
histochemistry (Fig. 5b, c). The percentage of MyHCI
positive fiber in ciSix1 KO mice increased to 90 %, and
the percentage of MyHCIIA positive fiber in ciSix1 KO
mice decreased to 10 %. This result showed that Six1 is
required for the maintenance of MyHCIIA expression in
SOL at the adult stage.
To compare the phenotypic consequences of Six1 de-
letion in the adult myofibers and during development,
mRNA expression levels of genes identified previously
were estimated in SOL of ciSix1 KO by qPCR. The ex-
pression of fast-type sarcomeric genes (MyHCIIX, MyH-
CIIA, Tnnt3, Tnni2, Tnnc2) was also down-regulated
(See figure on previous page.)
Fig. 4 Affymetrix microarray analysis in soleus of cSix1 mice. a Microarray analysis of soleus of 3-month-old cSix1 KO mice (n = 3) and Ctrl mice
(n = 3): a heat map of genes significantly upregulated (red) or downregulated (green) by twofold compared with Ctrl mice. b–f mRNA expression
levels of sarcomeric genes (b), energy metabolism (c), calcium regulation (d), transcription factors (e), and most down-regulated or up-regulated
genes (f) in soleus of 3-month-old cSix1 KO mice, Ctrl (n = 4), cSix1 (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001
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Fig. 5 (See legend on next page.)
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(Fig. 5d), consistent with immunohistochemistry results.
In contrast, we did not observe a significant up-
regulation of slow-type sarcomeric genes (MyHCI,
Tnnt1, Tnni1, Tnnc1), that may be related to the absence
of Sox6 down regulation (Fig. 5d). For genes controlling
glucose metabolism, we observed that the expression
level of glycolytic enzymes (Aldoa, Pfkfb1, and Eno3)
was down-regulated, and that the expression level of
Ldha and Pdk3 was not altered (Fig. 5e). Concerning
genes controlling calcium handling, mRNA level of
Pvalb was decreased by 90 % compared with that of Ctrl
mice, and an increase of Sln and Ryr3 mRNA levels was
observed (Fig. 5f ). mRNA level of fiber type regulators
such as Sox6 was not significantly changed between
ciSix1 KO mice and Ctrl mice (Fig. 5g), contrary to what
was observed in cSix1 KO. The decreased expression
level of Ddit4l, Rspo3, and Aldh1a1, and the increased
expression level of Cidea were also observed in the SOL
of ciSix1 KO mice (Fig. 5h). These data show that one
main function of Six1 in adult SOL could be to activate
the expression of a network of fast-glycolytic specific
genes among which are MyHCIIA, Aldoa, and Pvalb.
The modulation of slow-type genes expression was not
observed in the time window of 4 weeks following Six1
deletion, suggesting that it may take more time to com-
pletely transdifferentiate fast-MyHCIIA myofibers into
slow myofibers.
Pvalb is a direct target of Six1
A robust reduction of Pvalb mRNA observed in cSix1
KO mice and in ciSix1 KO mice led us to test the
hypothesis that Pvalb is a direct target of Six1. We ana-
lyzed the Pvalb promoter sequence and identified MEF3
regulatory elements. Two MEF3 sites located at −725 bp
(Pvalb MEF3-1) and −148 bp (Pvalb MEF3-2) from the
transcription start site of Pvalb were identified (Fig. 6a).
Six1 binding at these MEF3 sites was demonstrated in
vivo by ChIP experiments with Six1 antibodies on adult
fast GP and TA muscles (Fig. 6b) and confirmed for
both of these sites by EMSA assays with recombinant
Six1 and Six4 proteins (Fig. 6c). We next tested the tran-
scriptional activating potential of these elements in vivo
in transient transfection assays. A 748 bp DNA fragment
of the Pvalb promoter, including the two identified
MEF3 sites, was ligated to pGL3 basic plasmids to
generate pGL3-Pvalb constructs. Mutations of the two
MEF3 sites were introduced in the promoter sequence,
giving rise to Pvalb mut-MEF3-1, Pvalb mut-MEF3-2,
and Pvalbmut-MEF3-1/2. Luciferase activity was tested
after electroporation of these reporter plasmids in adult
TA muscles. The activity of a pGL3-Pvalb was 100-fold
higher than that of the empty pGL3 vector. Luciferase
activity was strongly decreased when the MEF3-2 site at
-148 was mutated. No further transcriptional decrease of
the Pvalb promoter was observed when both MEF3 sites
were mutated (Fig. 6d). Altogether, these results demon-
strate that Pvalb is a direct target of Six1, and that Six1
binding to the proximal MEF3 site present in the Pvalb
promoter is essential for its transcriptional activity in
vivo.
Discussion
In this study, we analyzed the subcellular distribution of
Six1 homeoprotein during postnatal development in
adult SOL muscle, and the consequences of Six1 loss
during muscle fiber type specialization. We showed that
Six1 proteins accumulated differentially in the myonuclei
of adult fast and slow fibers. Absence of Six1 delayed the
transition from embryonic MyHCemb fiber type to adult
fast-type MyHCIIA fiber type, leading to a concerted
down-regulation of the fast-type program and up-
regulation of the slow-type program. Transcriptomic
analysis of Ctrl and mutant SOL identified a network of
down-regulated and up-regulated genes upon Six1
deficiency. Particularly, Six1 is required in the SOL to
activate the expression of several fast sarcomeric genes,
glycolysis genes, fast-type calcium-handling genes as well
as Sox6, a repressor of slow genes. Conversely, up-
regulated expression was observed in Six1 mutant SOL
for numerous slow sarcomeric genes and for Prox1, a re-
pressor of fast genes. We further identified Pvalb, a key
player in intracellular Ca2+ buffering, as a direct target
of Six1. Altogether our analysis revealed that Six1 is an
essential genetic determinant of fast-type specialization
during the post-natal period, and that Six1 is required in
the adult for the maintenance of this phenotype.
Development of the fast-type IIA phenotype in SOL
Adult mouse SOL is composed of distinct types of myo-
fibers characterized by their contractile and metabolic
(See figure on previous page.)
Fig. 5 Tamoxifen-induced conditional muscle specific Six1 knockout reduced fast-type gene expression in soleus. a Six1 mRNA expression levels
in SOL of 3 month-old control (Ctrl, n = 3) and ciSix1 KO (n = 4) mice 1 month after tamoxifen injection. b Percentage of myofibers expressing
MyHCI or MyHCIIA in SOL of 3 month-old control (Ctrl, n = 3) and ciSix1 KO (n = 4) mice 1 month after tamoxifen injection. c Immunostaining of MyHCI
(red) and MyHCIIA (red) in SOL of 3 month-old control and ciSix1 KO mice 1 month after tamoxifen injection. Arrows indicate fibers expressing MyHCIIA,
and an arrow head indicates a fiber expressing both MyHCI and MyHCIIA in ciSix1 KO mice. d-g mRNA expression levels of sarcomeric genes (d), energy
metabolism (e), calcium regulation (f), transcription factors (g), and most down-regulated or up-regulated genes (h) in SOL of 3 month-old control
(Ctrl, n = 3) and ciSix1 KO (n = 4) mice 1 month after tamoxifen injection. *P < 0.05, **P < 0.01, ***P < 0.001
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Fig. 6 Pvalb is a direct target of Six1. a Schematic representation of the Pvalb promoter. b qPCR values of ChIP experiments performed with Six1
antibodies or IgG on GP and TA chromatin, and showing Six1 binding to Pvalb MEF3_1 and Pvalb MEF3_2. c Competitive Electromobility shift
assays performed with recombinant Six1 and Six4 proteins and labeled Myogenin MEF3 oligonucleotide and 10 or 100 fold molar excess of unlabelled
oligonucleotides containing Myogenin MEF3 site, NF1 site, or Pvalb MEF3_2 (left panel) and 100-fold molar excess of unlabelled oligonucleotides
containing Myogenin MEF3, NF1 site, Myod DRR MEF3 site, or Pvalb MEF3_1 sites (right pannel) whose sequence is presented on a. d Luciferase assays
from adult TA muscles electroporated by the indicated luciferase vectors and the TK-renilla luciferase vector allowing normalization.
*P < 0.05, ***P < 0.001
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properties and expressing either the slow MyHCI, the
fast MyHCIIA, or, more rarely, the fast MyHCIIX gene
[5]. We observed that the Six1 proteins accumulate dif-
ferentially in adult myonuclei, with a more pronounced
enrichment in fast fibers of the GP (Fig. 1) as compared
with the fibers of the SOL. However, Six1 mRNA and
total protein levels were found similar between SOL and
the fast GP [25]. Altogether, these observations suggest
that Six1 could be sequestered outside of most MyHCI
myonuclei, or actively retained in the nuclei of fast-type
fibers, and we show that this control takes place during
the perinatal period. Nevertheless, in the SOL Six1 pro-
teins coordinate the expression of genes specific of the
adult fast phenotype (Mybpc2, Tnni2, Tnnt3, Pvalb,
Sox6), most probably in MyHCIIA fibers where these
genes are coexpressed with MyHCIIA. Most of those
fast-type genes are also down-regulated in fast GP or TA
muscles of cSix1 mutant, as already reported [25], dem-
onstrating that Six1 acts as a major determinant of fast
type gene expression in the different fast fibers subtypes,
its absence leading to a “slower phenotype”. In the GP
and fast tibialis muscles, absence of Six1 leads to the
down regulation of MyHCIIB and MyHCIIX and the up-
regulation of MyHCI and MyHCIIA [25], while in the
SOL it abrogates MyHCIIX and MyHCIIA expression.
To explain this discrepancy one can suggest that the ab-
solute quantity of Six homeoproteins (Six1, Six2, Six4,
and Six5) present in the myonucleus tightly controls the
expression of the fast Myh genes cluster [52]; high levels
being required to activate MyHCIIB, while lower levels
would favor MyHCIIA expression. In fast muscles, ab-
sence of Six1 would lead to decrease the overall Six level
which would nevertheless remain sufficient to activate
MyHCIIA [25], while in the SOL the threshold of Six
proteins reached in absence of Six1 would not allow to
maintain MyHCIIA expression. Quantification of nuclear
Six2, Six4, and Six5 proteins remaining in SOL and GP
muscles of Six1 mutant mice may help testing this hy-
pothesis. Alternatively, other yet unidentified specific
transcription factors may compensate Six1 loss in fast
TA and GP muscles allowing MyHCIIA expression
observed in Six1cKO, while their absence in SOL would
preclude MyHCIIA expression. Identification of the
transcription factor machinery present specifically in
MyHCIIA, MyHCIIX and MyHCIIB myofibers and
responsible for the expression of a single fast Myh gene
at the locus remains to be established. We also observed
that in cSix1 mutant SOL, SDH and GPDH activities are
decreased, and that many genes coding for glycolytic
proteins are downregulated. More particularly, we
identified a decrease of Phosphofructo-kinase, of Aldola-
seA, of Glyceraldehyde-3-phosphate dehydrogenase and
of Enolase 3 mRNAs, arguing for a decreased glucose
use in cSix1 mutant SOL. Furthermore, we observed an
increase of Pdk3 and a decrease of Pdp1 mRNAs, which
should lead to a decrease of Pyruvate Dehydrogenase ac-
tivity and consequently a decrease of acetyl CoA produc-
tion. Last, expression of Isocitrate dehydrogenase 3, higher
in MyHCIIA and MyHCIIX myofibers [5], is also de-
creased in mutant SOL. Altogether these results suggest a
concerted control of sarcomeric genes and of genes con-
trolling glucose metabolism by Six1 homeoproteins.
We observed that 3-week-old animals show already a
lower accumulation of Six1 in myonuclei of the SOL as
compared to the fast gastrocnemius. Mechanisms under-
lying Six1 nucleocytoplasmic shuttle and specific accu-
mulation in perinatal and adult fast myofibers remain to
be identified. At birth, SOL myofibers express the em-
bryonic MyHCemb, neonatal and the slow MyHCI genes
[53]. Fast MyHCIIA is detected at the mRNA level at
post-natal stages, and its expression increases during the
3 weeks after birth at the expense of MyHCemb and
MyHCneo, whose expression declines with neuromuscu-
lar junction (NMJ) maturation [2]. We observed that in
cSix1 SOL the transition from MyHCemb to MyHCIIA is
impaired, and that three weeks old mutant animals still
express MyHCemb in the SOL, showing the requirement
of Six1 for the transition from embryonic Myh to adult
Myh expression and myofiber specialization.
During post-natal development, three main factors are
involved in the emergence of adult myofiber specialization
[2] and that may control Six1 accumulation specifically in
fast myonuclei.
The first factor involves the influence of slow and fast
neuromuscular junctions. Myofibers are still polyinner-
vated at birth in the SOL, and retraction of polyinnerva-
tion only takes place in the first weeks after birth giving
rise to slow–twitch fatigue resistant and fast–twitch fa-
tigue resistant alpha motoneurons on slow/MyHCI and
fast/MyHCIIA myofibers, respectively [54, 55]. During
this period, in the rodents’ SOL, the expression of em-
bryonic and neonatal Myh is replaced by the expression
of either adult MyHCI or MyHCIIA [53, 56]. Accord-
ingly, low Six1 nuclear accumulation in MyHCI myofi-
bers may be the consequence of slow motoneurons
activity. The main second messenger of slow tonic firing
in the myofiber is the Ca++ concentration flux that
modulates Calcineurin and CaMK activities [57].
Calcineurin phosphatase activity then controls the sub-
cellular localization of NFATc transcription factors [14,
58]. Calcineurin signaling from the perinatal period on
appears to be essential for fiber-type specialization, as
supported by experiments in transgenic animals showing
that its blockade by forced MCIP1 expression impairs
slow fibers specialization [59].
In SOL of Myod1-MCIP1 transgenic mice, Myoglobin
expression is not reduced, while the expression of MyHCI
is downregulated from day 7 and is undetected from day
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14 [59]. We did not detect in cSix1KO or ciSix1 SOL
modification of the expression of Myoglobin, suggesting
that in both cases mutant myofibers are not completely
reprogrammed. Transient Six1 expression in perinatal
myofibers of cSix1 SOL may explain why MyHCIIA is
transiently expressed in the perinatal period, until the end
of SC accretion that takes place in the first 3 weeks post
natal [39], and of regular Six1 positive nuclei supply. Thus,
the incomplete reprogramming observed in adult cSix1
mutant SOL may be the consequence of accretion of new
satellite cells into the growing post-natal fast MyHCIIA
myofibers that provides transiently a genetically or epige-
netically programmed fast phenotype that impairs their
total reprogramming.
It is known that MyHCI expression during the peri-
natal period as well as in the adult is nerve-dependent
[60–62]. Accordingly, all cSix1 mutant SOL myofibers
that express only MyHCI should be innervated by slow
motoneurons. We observed a strong decrease of the ex-
pression of R-Spondin3 (Rspo3) in cSix1 mutant myofi-
bers. R-spondins are secreted proteins known to
enhance Wnt/β-catenin signaling [63] which is a major
actor of neuromuscular jonctions (NMJ) [64]. Mice mu-
tant for β-catenin in the myofiber show presynaptic differ-
entiation defects [65]. Whether a Rspo3/β-catenin
pathway controlled by Six1 may favor specific stabilization
of fast–twitch fatigue resistant alpha motoneuron on fu-
ture MyHCIIA myofibers is an interesting issue that re-
mains to be tested. Related to this observation, we noted
the increase of the expression of Chnrγ and Chnrα1, sug-
gesting NMJ remodeling in cSix1 SOL.
A second important mechanism involved in fast myo-
fiber specialization during the perinatal period concerns
the influence of thyroid hormone [66, 67]. In agreement,
hypothyroidic animals show delayed fast Myh transition
and prolonged MyHCemb expression [68], a phenotype
also found in cSix1 mutant SOL. Affymetrix transcrip-
tomic analysis did not reveal a link between the presence
of Six1 in SOL and the level of thyroid receptors (TR) or
TR co-factors expression. This suggesting that the ab-
sence of fast phenotype acquisition in cSix1 mutant SOL
is not due to a decreased expression of TR, although
more detailed analysis of the expression of miR-133a1, a
direct TR target gene in adult skeletal muscle involved
in the control of TEAD1 expression [67], remains to be
performed. While Six1 does not control TR expression
in SOL, the possibility that nuclear Six1 accumulation in
fast myofibers could be controlled by the thyroid hor-
mone axis remains an interesting possibility.
A third factor that may participate in myofiber
specialization involves intrinsic cell autonomous differ-
ences in distinct population of myogenic progenitors
leading to myofibers heterogeneity. It is suspected that
adult satellite cells associated with slow or fast muscles
have intrinsic different genetic properties, although ex-
trinsic factors arising in extracellular matrix or from
muscle position and usage in the limb has not been
completely excluded [69]. It is therefore tempting to
speculate that satellite cells (SC), associated with future
MyHCIIA and MyHCI myofibers in the SOL, accreted
in the growing myofiber during post-natal development
possess specific heritable properties. As myonuclei
present in the SOL at 3 weeks show lower Six1 accumu-
lation as compared with myonuclei of the GP, this may
suggest that perinatal SC accreted in growing SOL and
GP myofibers express different level of Six1, depending
of their localization in the niche of MyHCI or subtypes
of fast Myh myofibers. It would thus be interesting to
test Six1 expression level in GP and SOL associated SC
to confirm this hypothesis.
Fast MyHCIIA expression in adult soleus
In the mammalian genome, a number of genes are orga-
nized in clusters such as the β-globin [70], the Hox [71],
and the fast Myh cluster [52]. Within these clusters, the
precise order of the genes allows their sequential expres-
sion through shared enhancers. We showed previously
that in adult fast TA and GP muscles Six1 is bound on a
central enhancer located at the Myh fast locus between
MyHCemb and MyHCIIA, and that it controls the ex-
pression of MyHCIIB [25]. We show here that in
addition Six1 is essential for efficient fiber type shift
from MyHCemb to MyHCIIA in SOL muscles during
postnatal development (Fig. 2). The above mentioned
fast Myh enhancer is able to activate the transcription of
the MyHCIIX, MyHCIIA and MyHCIIB genes and may
control higher order chromatin conformation at the
locus to allow a single fast Myh gene to be expressed in
all myonuclei of each fiber [25]. MyHCIIA activation
during the perinatal period in SOL may also depend on
this enhancer, and on its own promoter elements known
also to interact with Six1 [25, 72].
It will be of major interest to unravel the mechanisms
presiding the choice of the expression of a single fast
Myh gene at the locus in a given myofiber during the
perinatal period, its coordinated associated metabolic
specialization and the involvement of Six1 in this matter.
In the case of the β-globin, an LCR localized upstream
of Globin genes controls the spatiotemporal and sequen-
tial expression of each gene at the locus. The transcrip-
tion factor Sox6 binds to each private Globin regulatory
elements and coordinates the interactions with the LCR
through chromatin conformation modification [73, 74].
Interestingly, Sox6 also binds intergenic regions of Myh
locus in C2 myotubes [22, 24]. An interesting hypothesis
would thus be that mechanisms similar to those controlling
the β-globin locus could act at the Myh locus with Six1 and
Sox6 cooperating to orchestrate the spatiotemporal
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expression of the Myh fast genes. Sox6 mRNA is expressed
in adult fast type muscles, not in slow type muscles [22],
and skeletal muscle specific Sox6 knockout mice showed
fiber type transition from fast to slow. cSix1 KO SOL mice
have an increased expression of slow type genes that may
be partly the consequence of decreased expression of Sox6
mRNA level observed. We have shown previously that Six
homeoproteins also control the nuclear accumulation of
Sox6 in fetal muscle [29], and we cannot exclude that in
cSix1 KO this is not also the case. It would be interesting to
determine whether Six1 is relocalized ouside of the nucleus
in adult Sox6 mutant myofibers since all myofibers in SOL
of Sox6 mutant mice express MyHCI [22, 24] and that in
transgenic mice overexpressing Sox6 the expression of slow
type genes like MyHCI and Tnni1 is down regulated [75].
The consequence of Sox6 down regulation observed in
cSix1 SOL may also be responsible of Prox1 up regulation.
Prox1 is a known repressor of fast muscle gene expression
in Zebrafish lying downstream of Sox6 [76] and its deletion
in mouse leads to increased expression of fast MyHCIIA,
Tnni2, and Tnnt3 genes in SOL [49]. Analysis of the conse-
quences of Prox1 knock down in cSix1 SOL would allow to
test its involvement in the down regulation of MyHCIIA,
Tnni2, and Tnnt3.
Six genes redundancy in adult myofibers
In our study, HSA-CREert2 recombinase induced dele-
tion of Six1 in 2 months adult myofibers led to a switch
toward a slow phenotype within 4 weeks following Six1
deletion. This inducible switch was characterized by the
decreased expression of MyHCIIX, MyHCIIA, Pvalb,
AldoA, and Eno3 and an increased number of MyHCI
positive myofibers. In this model, the up-regulation of
slow-type muscle genes 4 weeks after Six1 deletion was
less obvious than observed in HSA-CRE animals, pos-
sibly because in this paradigm the expression of Sox6,
which inhibits a battery of slow muscle genes, is faintly
down-regulated. It is possible that during this time
period, Six1 direct targets are efficiently down-regulated,
while the up-regulation of slow-type genes might require
other modifications such as a switch from fast to slow
innervation, and/or decrease of Sox6 expression. Fur-
thermore, the nuclear level of Six4 and Six5 homeopro-
teins, both expressed in adult myofibers, might be
higher in SOL of ciSix1 than in cSix1. In adult muscles,
the Six4-Baf60c transcription complex controls Deptor
expression and transgenic animals with muscle-specific
forced expression of Deptor show a switch from oxida-
tive to glycolytic metabolism and are protected from
diet-induced insulin resistance [77]. In cSix1 mutant
SOL, the level of Deptor mRNA is unchanged, suggest-
ing that the specific Six4/Deptor genetic axis, if main-
tained in cSix1 mutant SOL, is sufficient to maintain the
level of expression of genes coding for proteins of the
glycolytic pathway. cSix1 SOL presents a severe decrease
of GPDH enzymatic activity, which may be correlated to
a decreased expression of Gpd1 in mutant myofibers.
Whether further decreased Six activity by combining Six1
and Six4 loss in adult myofibers would lead to increased
defects of glycolytic flux remains to be evaluated.
Pvalb is a calcium binding protein responsible for fast
calcium concentration decrease and relaxation in fast
type muscle fiber after excitation. Pvalb knockout mice
showed prolonged contraction-relaxation cycle [11] and
increased fatigue resistance [44] associated with in-
creased mitochondria composition without major modi-
fications of fiber type specific sarcomeric proteins [43].
We demonstrated that Pvalb is a direct target of Six1
(Fig. 6), but did not observe up regulation of oxidative
metabolism components neither at the mRNA level nor
at the protein level (Figs. 3, 4, 5, and 6) in cSix1 mutant
SOL, with on the contrary a decreased SDH activity.
Recent study with single fiber proteomics revealed that
MyHCI fibers have less mitochondrial proteins and SDH
activity compared to MyHCIIA fibers [5]. The loss of
MyHCIIA fiber in SOL of Six1 KO mice might explain the
decreased SDH activity observed. In addition, down-
regulation of Esr1 (estrogen receptor 1), which is known
to activate mitochondrial oxidation activity in females
[48], was also observed in SOL muscles of cSix1 KO
males. These changes may participate in down-regulation
of oxidative metabolism in mutant samples (Fig. 3). In that
context, down regulation of Esr1 could cancel the effect of
Pvalb expression decrease in regard of mitochondrial
activity.
Conclusions
We present the evidence that Six1 homeoproteins are
required in mouse SOL muscles for the acquisition of
the fast MyHCIIA phenotype by controlling MyHCIIA
expression and the expression of other fast-type muscle
genes among which Sox6, and by controlling efficient
glucose utilization through the control of glycolytic and
of Krebs cycle genes.
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